Comprehensive Guide to Handling Regulatory Non-Conformances in Medical Device Manufacturing
1) Purpose
The purpose of this SOP is to establish a standardized approach for identifying, documenting, investigating, and resolving regulatory non-conformances in medical device manufacturing. Proper handling ensures compliance with applicable regulations, minimizes risks, and supports continuous improvement.
2) Scope
This SOP applies to all instances of non-conformances identified through internal audits, regulatory inspections, customer complaints, or other sources. It is relevant to quality assurance, regulatory affairs, production, and risk management teams.
3) Responsibilities
– Quality Assurance (QA): Oversees the process of documenting, investigating, and resolving non-conformances.
– Regulatory Affairs: Ensures timely reporting to regulatory bodies if required and monitors compliance.
– Department Heads: Implement corrective and preventive actions (CAPA) within their areas of responsibility.
– Risk Management Team: Updates risk assessments based on findings and corrective actions.
– Training Coordinators: Train personnel on non-conformance handling and related procedures.
4) Procedure
4.1 Identification of Non-Conformances
4.1.1 Sources of Non-Conformance
– Non-conformances may be identified through:
– Internal or external audits.
– Regulatory inspections.
– Customer complaints.
– Adverse events or post-market surveillance.
– Production line deviations.
4.1.2 Categorization
– Classify non-conformances based on severity:
– Major: May impact product quality or regulatory compliance but without immediate safety concerns.
– Minor: Does not affect product safety or compliance but requires correction.
4.1.3 Initial Notification
– Report identified non-conformances immediately to the QA and Regulatory Affairs teams.
– Log details in the Non-Conformance Log, including:
– Date of identification.
– Source and description of the issue.
– Initial categorization.
4.2 Investigation of Non-Conformance
4.2.1 Assign Investigation Team
– Form an investigation team with members from relevant departments, including QA, production, and regulatory affairs.
– Assign a lead investigator to coordinate activities and documentation.
4.2.2 Root Cause Analysis
– Perform root cause analysis (RCA) using tools such as:
– Fishbone Diagram.
– 5 Whys.
– Fault Tree Analysis.
– Document findings, including:
– Contributing factors.
– Underlying root causes.
– Risk assessment updates.
4.2.3 Documentation
– Prepare an Investigation Report summarizing:
– Non-conformance details.
– Investigation methods and findings.
– Impact assessment on product quality, safety, or compliance.
4.3 Corrective and Preventive Actions (CAPA)
4.3.1 Development of CAPA Plan
– Develop a CAPA plan for addressing non-conformance, including:
– Corrective actions to resolve the immediate issue.
– Preventive actions to address root causes and prevent recurrence.
– Timelines and responsible personnel.
4.3.2 Implementation
– Implement CAPA actions as per the approved plan.
– Monitor progress and document completion of each action.
4.3.3 Verification of Effectiveness
– Verify the effectiveness of CAPA actions through follow-up audits or inspections.
– Document results in the CAPA Log and update the Non-Conformance Log accordingly.
4.4 Reporting to Regulatory Authorities
4.4.1 Determining Reporting Requirements
– Assess whether the non-conformance is reportable under applicable regulations, such as:
– FDA Medical Device Reporting (MDR) requirements.
– EU MDR Vigilance Reporting.
– Local regulatory reporting obligations.
4.4.2 Preparing and Submitting Reports
– Prepare a formal report to the regulatory authority, including:
– Description of the issue and root cause.
– Corrective actions taken.
– Risk assessment and preventive measures.
– Retain submission confirmation and correspondence for audit purposes.
4.5 Continuous Monitoring and Improvement
4.5.1 Trend Analysis
– Conduct regular analysis of non-conformance data to identify recurring issues or patterns.
– Use insights to prioritize improvements in processes, training, or systems.
4.5.2 Training
– Provide training on lessons learned from non-conformance handling.
– Update relevant SOPs, work instructions, or quality management documents as needed.
4.5.3 Internal Audits
– Schedule periodic internal audits to assess compliance with CAPA plans and ensure sustained improvement.
4.6 Record Retention
– Retain all records related to non-conformances for at least five years or as required by regulatory authorities.
– Ensure records are securely stored and easily accessible for audits or inspections.
5) Abbreviations
– QA: Quality Assurance
– CAPA: Corrective and Preventive Actions
– FDA: Food and Drug Administration
– EU MDR: European Medical Device Regulation
– RCA: Root Cause Analysis
– SOP: Standard Operating Procedure
6) Documents
– Non-Conformance Log
– Investigation Reports
– CAPA Plans and Logs
– Regulatory Reporting Records
– Training Logs
– Audit Reports
7) Reference
– FDA CFR Title 21, Part 820: Quality System Regulation
– EU MDR (Regulation (EU) 2017/745): Post-Market Surveillance and Vigilance
– ISO 13485: Medical devices – Quality management systems
– ISO 14971: Application of Risk Management to Medical Devices
8) SOP Version
– Version: 1.0
– Effective Date: DD/MM/YYYY
– Approved by: [Name/Title]
Annexure
Annexure 1: Non-Conformance Log Template
| Date | Non-Conformance ID | Description | Category | Status | Responsible Team |
|---|---|---|---|---|---|
| DD/MM/YYYY | NC-001 | Incomplete risk assessment | Major | Open | Regulatory Affairs |
Annexure 2: CAPA Log Template
| Date | CAPA ID | Description | Corrective Action | Preventive Action | Status |
|---|---|---|---|---|---|
| DD/MM/YYYY | CAPA-001 | Labeling error | Update labeling system | Revise SOP | Completed |